Jintao He

Jintao He

Auto-generated profile, based on publicly available information

Jintao He

Laboratory Medicine Center, Department of Clinical Laboratory, Zhejiang Provincial People's Hospital, Affiliated People's Hospital, Hangzhou Medical College, Hangzhou 310014, China

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 July 2024 in International Journal of Antimicrobial Agents
Verified
Journal Article
Closed access
XHXinhong Han
Xinhong Han
JYJiayao Yao
Jiayao Yao
JHJintao He
Jintao He
HLHaiyang Liu
Haiyang Liu
YJYan Jiang
Yan Jiang
XLXi Li
Xi Li

1 January 2020 in Infection and Drug Resistance
Verified
Journal Article
Open access
PDF file
LHLihua Hu
Lihua Hu
YSYue Shi
Yue Shi
QXQingye Xu
Qingye Xu
LZLinghong Zhang
Linghong Zhang
JHJintao He
Jintao He
ZZZhihui Zhou
Zhihui Zhou
Background: Acinetobacter baumannii is a nosocomial pathogen of critical importance due to the increasing numbers of antibiotic-resistant isolates. Colonies can have a smooth or matt appearance, but also exhibit slimy, mucoid growth, with the latter being increasingly isolated in patients in recent years. Methods: We isolated 60 A. baumannii strains from altogether 56 patients and found that all patients were infected by mucoid strains, with four patients having also matt phenotypes in addition to the mucoid ones. The morphology of the colonies and capsules was observed. The antibiotics susceptibilities were tested, and the biofilm formation ability was determined by crystal violet staining. The whole-genome sequencing (WGS) was performed on all the strains, and then the core genome multilocus sequence typing (cgMLST) and drug resistance gene analysis were performed. Finally, a part of isolates were selected to test virulence in a Galleria mellonella model. Results: We observed much larger capsules in the mucoid strains compared to the matt isolates. But the mucoid phenotype did not correlate with the amount of biofilm produced by the strain. Almost all mucus-type A. baumannii were multi-drug resistant isolates, containing various antibiotic resistance genes. The main ST types of mucoid-type A.baumannii were ST191 and ST195, of which ST191 isolates were more virulence, while ST195 isolates were weaker. Conclusion: The mucoid A. baumannii had resistance to most antibiotics and some strains had high virulence, which should be paid attention in clinical.

16 May 2024 in Antibiotics
Verified
Journal Article
Open access
PDF file
SYSiyuan Yang
Siyuan Yang
JFJian-zhong Fan
Jian-zhong Fan
LYLifei Yu
Lifei Yu
JHJintao He
Jintao He
LZLinghong Zhang
Linghong Zhang
Xiaoting HuaXiaoting Hua
Xiaoting Hua
Salmonella Enteritidis was the primary foodborne pathogen responsible for acute gastroenteritis. The growing ceftriaxone resistance poses a significant threat to public health. Infection with S. Enteritidis has emerged as a major public health concern, particularly in developing countries. However, research on ceftriaxone-resistant S. Enteritidis (CRO-RSE) remains limited, particularly concerning its resistance mechanism, plasmid structure, and transmission characteristics. This study aims to address these gaps comprehensively. We collected 235 S. Enteritidis isolates from Hangzhou First People’s Hospital between 2010 and 2020. Among these, 8.51% (20/235) exhibited resistance to ceftriaxone. Whole-genome analysis revealed that 20 CRO-RSE isolates harbored blaCTX-M-55 or blaCTX-M-14 on the plasmid. Moreover, the dissemination of the blaCTX-M-type gene was associated with IS26 and ISEcp1. Plasmid fusion entailing the integration of the p1 plasmid with antibiotic resistance genes and the p2 (pSEV) virulence plasmid was observed in certain CRO-RSE. Additionally, the structural analysis of the plasmids unveiled two types carrying the blaCTX-M-type gene: type A with multiple replicons and type B with IncI1 (Alpha) replicon. Type B plasmids exhibited superior adaptability and stability compared to type A plasmids within Enterobacteriaceae. Interestingly, although the type B (S808-p1) plasmid displayed the potential to spread to Acinetobacter baumannii, it failed to maintain stability in this species.

19 March 2026 in EBioMedicine
Verified
Journal Article
Open access
XLXi Li
Xi Li
XHXinhong Han
Xinhong Han
XTXinyan Tang
Xinyan Tang
ZFZhaokun Fan
Zhaokun Fan
LDLi Ding
Li Ding
YYYunsong Yu
Yunsong Yu
KPC and NDM co-producing carbapenem-resistant Klebsiella pneumoniae (KN-CRKP) is an escalating global health threat with limited treatment options. Here, we conducted a multicentre retrospective case-control study on KN-CRKP in China (2020-2025), collecting 3012 non-duplicated CRKP isolates, of which 71 (2.4%) were KN-CRKP. For clinical analysis, 39 patients with KN-CRKP infections were identified from 71 isolates and matched in a 1:2 ratio with 78 patients infected by KPC-2-producing CRKP. For global analysis, we retrieved 100,141 genomes from GenBank, of which 662 non-redundant KN-CRKP sequences were combined with our 71 KN-CRKP isolates. Antimicrobial susceptibility testing, whole-genome sequencing (WGS), plasmid transfer and stability, fitness cost, transcriptomics and Bayesian phylogeography were used to investigate evolution mechanisms and molecular epidemiology of KN-CRKP strains. Among the infected patients, hospital-acquired or ventilator-associated pneumonia was the most common (41.0%, 16/39). Patients with KN-CRKP infections had a non-significantly higher 28-day mortality (38.5%, 15/39) than the KPC-CRKP control group (24.4%, 19/78; p = 0.133), but a significantly higher in-hospital mortality (46.2%, 18/39 vs. 25.6%, 20/78; p = 0.036). Independent risk factors included diabetes, a history of CRO (carbapenem-resistant gram-negative organism) infection treated with ceftazidime-avibactam (CZA) treatment, and recent use of β-lactam/β-lactamase inhibitor combinations. All KN-CRKP isolates were resistant to carbapenems and CZA, but exhibited highly susceptible to colistin (98.6%), cefiderocol (94.4%), and aztreonam-avibactam (100%). The predominant KN-CRKP clones were ST11 (73.2%) and ST307 (15.5%). Global surveillance of 733 global KN-CRKP identified ST11 as a pandemic lineage diverging into China/Brazil subclusters, with emerging clones ST147/ST307 showing post-pandemic increases. Plasmid profiling revealed blaNDM mainly on IncX3/IncN plasmids and blaKPC on IncR/IncFII plasmids, with novel hybrid plasmids carrying both carbapenemases identified. blaNDM-carrying plasmids had higher transferability/stability than blaKPC-carrying ones. In vitro experiments confirmed blaNDM transfer from Citrobacter freundii to blaKPC-carrying K. pneumoniae, forming KN-CRKP. The high mortality and global prevalence of KN-CRKP emphasise the need for enhanced surveillance and infection control globally. National Natural Science Foundation of China (82472323 and 82172306), Zhejiang Province Natural Science Foundation of China (LQN26H200003, LR25H200001, LQN25H200002, MS25H190009), the "Pioneer" and "Leading Goose" R&D Program of Zhejiang Province (2025C02187), the Zhejiang Provincial Medical and Health Technology Project (2025HY0224) and Zhejiang Provincial Disease Prevention and Control Science and Technology Program (2025JK063). We appreciate the statistical support provided by Hui Liu (Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China).

30 May 2026 in Drug Resistance Updates
Verified
Journal Article
Closed access
HHHaijun Huang
Haijun Huang
LZLongjie Zhou
Longjie Zhou
HXHaotian Xu
Haotian Xu
QLQianhao Liu
Qianhao Liu
LWLinfang Wang
Linfang Wang
HZHua Zhou
Hua Zhou

16 February 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
HLHaiyang Liu
Haiyang Liu
XLXiaochen Liu
Xiaochen Liu
JHJintao He
Jintao He
HZHong ling Zhang
Hong ling Zhang
FZFeng Zhao
Feng Zhao
YYYunsong Yu
Yunsong Yu
Carbapenem-resistant Acinetobacter baumannii (CRAB) isolates of global clone 1 (GC1) and global clone 2 (GC2) have been widely reported. Nevertheless, non-GC1 and non-GC2 CRAB strains have been studied less. In particular, no reports concerning sequence type 46 (ST46Pas) CRAB strains have been described thus far. In this work, the genomic features and possible evolution mechanism of ST46Pas OXA-23-producing CRAB isolates from clinical specimens are reported for the first time. Antimicrobial susceptibility testing of three ST46Pas strains revealed identical resistance profiles (resistance to imipenem, meropenem, ciprofloxacin and the combination of cefoperazone/sulbactam at a 2:1 ratio). They were found to belong to ST46Pas and ST462Oxf with capsular polysaccharide 28 (KL28) and lipooligosaccharide 1 (OCL1), respectively. Whole-genome sequencing (WGS) revealed that all contained one copy of chromosomal blaOXA-23, which was located in a novel ISAba1-based Tn7534 composite transposon. In particular, another copy of the Tn7534 composite transposon was identified in an Hgz_103-type plasmid with 9 bp target site duplications (TSDs, ACAACATGC) in the A. baumannii ZHOU strain. As the strains originated from two neighboring intensive care units (ICUs), ST46Pas OXA-23-producing CRAB strains may have evolved via transposition events or a pdif module. Based on the GenBank database, ST46Pas strains were collected from various sources; however, most were collected in Hangzhou (China) from 2014 to 2021. Pan-genome analysis revealed 3276 core genes, 0 soft-core genes, 768 shell genes and 443 cloud genes shared among all ST46Pas strains. In conclusion, the emergence of ST46Pas CRAB strains might present a new threat to healthcare settings; therefore, effective surveillance is required to prevent further dissemination.